• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Clinical trials

Lisocabtagene maraleucel meets its primary endpoint of complete response rate in R/R CLL and S...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Restoring the delicate coagulation balance in haemophilia
  • Non-myeloablative haploidentical haematopoietic stem cell transplantation for adult patients with sickle cell disease: Current status and future perspectives
  • Unveiling cytokine profiles: HLH induced by the combination of cemiplimab and venetoclax
  • Clinical importance of screening for the neglected acquired von Willebrand syndrome in patients with myeloproliferative neoplasms: A case series
  • Journal scan
  • New haematology reimbursements in Belgium
Clinical trials

Impressive response with immuno- plus chemotherapy in patients with Hodgkin’s lymphoma

Read more
Clinical trials

No survival benefit from adding gilteritinib to azacitidine in newly-diagnosed FLT3-mutated pa...

Read more
Clinical trials

Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia

Read more
Clinical trials

Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients

Read more
Clinical trials

Prolonged PFS with zanubrutinib in untreated CLL/SLL patients

Read more
Clinical trials

Triple combination of obinutuzumab, acalabrutinib and venetoclax not (yet) recommended in pati...

Read more
Clinical trials

Lenalidomide plus rituximab is an efficient chemo-free alternative for patients with advanced ...

Read more
Clinical trials

Sutimlimab reduces haemolysis, anaemia, and fatigue in patients with CAD without transfusion r...

Read more
Previous 4 5 6 7 8 9 10 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025